POWERED BY AO-BIOTICS AO-Biotics is a precision prebiotic designed to boost animal resilience to challenges
they are a proven therapy and a research compound whose clinical development was abandoned in 2007
These and other studies gave impetus to the clinical development of the inhibitors of DPP-4 for diabetes therapy, and in a pivotal proof-of concept study by Ahren and coworkers in 2004, vildagliptin, developed by researchers at Novartis, showed hemoglobin A1c improvements to target levels of 7% in a 1-year trial, whereas a significant rise was observed in the placebo group (103)
Many SWMPs have publicly acknowledged obesity as a disease that requires personalized treatment, have introduced GLP-1-related offerings, and have highlighted that they may be able to help fill care gaps in treating obesity with medications
Effect of subcutaneous semaglutide vs placebo on body weight and cardiometabolic risk factors
A 2009 study published in Toxicology and Industrial Health has found that mold and mycotoxin exposure from water-damaged and mold-infested buildings may lead to neurological and neuropsychiatric issues (8)